|
Volumn 51, Issue 1, 1999, Pages 3-8
|
Design of protease inhibitors on the basis of substrate stereospecificity
|
Author keywords
A chymotrypsin; Inhibitor design; Papain; Stereochemical approach; Substrate stereospecificity
|
Indexed keywords
CATALYST ACTIVITY;
CATALYST DEACTIVATION;
CHEMICAL BONDS;
ENZYME KINETICS;
ESTERS;
MATHEMATICAL MODELS;
MOLECULAR ORIENTATION;
MOLECULAR STRUCTURE;
CHYMOTRYPSIN;
STEREOSPECIFICITY;
ENZYME INHIBITION;
2 BENZYL 3,4 EPOXYBUTANOIC ACID METHYL ESTER;
CHYMOTRYPSIN A;
PAPAIN;
PROTEINASE INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG CONFORMATION;
DRUG DESIGN;
DRUG PROTEIN BINDING;
ENZYME ACTIVE SITE;
ENZYME INACTIVATION;
ENZYME SPECIFICITY;
NONHUMAN;
PROTEINASE INHIBITION;
STEREOSPECIFICITY;
STRUCTURE ACTIVITY RELATION;
BINDING SITES;
CHYMOTRYPSIN;
DRUG DESIGN;
PAPAIN;
PROTEASE INHIBITORS;
STEREOISOMERISM;
SUBSTRATE SPECIFICITY;
|
EID: 0033037117
PISSN: 00063525
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0282(1999)51:1<3::AID-BIP2>3.0.CO;2-Q Document Type: Article |
Times cited : (6)
|
References (25)
|